Concepedia

Michael Woloschak

MW

Statistics

Publications

17

Citations

997

H-Index

16

Active since

1989

Affiliations

Icahn School of Medicine at Mount Sinai(Current)

Novartis (United States)

Roche (Switzerland)

Novartis (China)

National Institute of Diabetes and Digestive and Kidney Diseases

Michael Woloschak is an author at Icahn School of Medicine at Mount Sinai specializing in medicine, pituitary tumors, and pituitary tumorigenesis.

Publications per year

1989–2021

17

Publications

17

Developmental regulation of the rat insulin-like growth factor I receptor gene.

Hauke Werner, Michael Woloschak, Martin L. Adamo et al. · Proceedings of the National Academy of Sciences · 1989 · 339 citations · Full text

, , +10

Frequent loss of the P16INK4a gene product in human pituitary tumors.

Michael Woloschak, Aiqin Yu, Jiaqi Xiao et al. · PubMed · 1996 · 102 citations

, , +17

Frequent inactivation of thep16 gene in human pituitary tumors by gene methylation

Michael Woloschak, Aiqin Yu, Kalmon D. Post · Molecular Carcinogenesis · 1997 · 98 citations

, , +17

Loss of heterozygosity at the retinoblastoma locus in human pituitary tumors

Michael Woloschak, James L. Roberts, Kalmon D. Post · Cancer · 1994 · 52 citations · Full text

, , +15

Efficacy and Safety of Taspoglutide Versus Sitagliptin for Type 2 Diabetes Mellitus (T-Emerge 4 Trial)

Richard M. Bergenstal, Adriana Costa e Forti, Jean‐Louis Chiasson et al. · Diabetes Therapy · 2012 · 47 citations · Full text

, , +15

1–5 of 17